AbbVie Inc

NYSE : ABBV

Industry : Pharmaceuticals | ISIN : US00287Y1091 | FreeFloat : 99.88% | FnO : Yes | LotSize : 100


Intellectual Capital (IC)595,108.90
Net Worth (NW)16,027.00
Intrinsic Worth (IW)611,135.90
Market Cap (MC)238,357.00
Economic Value Added2,981.17
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)97.38%
IC Gross Margin (EBITDA/IC)4.03%
IC Net Margin (NPT/IC)2.23%
Knowledge Turnover (Sales/IC)0.11
Market to Intrinsic Value (MC/IW)0.39

As OfIntrinsic ValueMarket Price
Sep 30 2022$ 344.11$ 134.21
Jan 26 2023 ---- $ 147.40
-0.39     -0.26%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : $ 149.69SellAvoid
KB > 50% : Yes50 DMA : $ 158.69
0 < M2IV < 1 : YesVol-Price trend : Falling
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results ($ Mn)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-19
C
8704.00
8138.00
4142.00
3633.00
3074.00
2801.00
2801.00
Mar-20
C
8619.00
8542.00
4220.00
3661.00
3098.00
3010.00
3010.00
Jun-20
C
10425.00
9594.00
1494.00
-61.00
-693.00
-738.00
-737.00
Sep-20
C
12902.00
12767.00
5422.00
3130.00
2500.00
2313.00
2308.00
Dec-20
C
13858.00
8916.00
1187.00
-878.00
-1507.00
38.00
36.00
Mar-21
C
13010.00
13326.00
6714.00
4499.00
3867.00
3555.00
3553.00
Jun-21
C
13959.00
11190.00
3978.00
1778.00
1163.00
769.00
766.00
Sep-21
C
14342.00
13919.00
6411.00
4284.00
3688.00
3180.00
3179.00
Dec-21
C
14886.00
14886.00
5661.00
4858.00
4271.00
4045.00
4044.00
Mar-22
C
13538.00
13538.00
4929.00
4929.00
4929.00
4493.00
4490.00
Jun-22
C
14583.00
14607.00
3791.00
1739.00
1183.00
928.00
924.00
Sep-22
C
14812.00
14812.00
7102.00
4897.00
4400.00
3952.00
3949.00
* C - Consolidated, S - Standalone